432 related articles for article (PubMed ID: 26251078)
1. Non-O blood groups can be a prognostic marker of in-hospital and long-term major adverse cardiovascular events in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Cetin MS; Ozcan Cetin EH; Aras D; Topaloglu S; Temizhan A; Kisacik HL; Aydogdu S
Thromb Res; 2015 Sep; 136(3):599-605. PubMed ID: 26251078
[TBL] [Abstract][Full Text] [Related]
2. Platelet to Lymphocyte Ratio as a Prognostic Marker of In-Hospital and Long-Term Major Adverse Cardiovascular Events in ST-Segment Elevation Myocardial Infarction.
Ozcan Cetin EH; Cetin MS; Aras D; Topaloglu S; Temizhan A; Kisacik HL; Aydogdu S
Angiology; 2016 Apr; 67(4):336-45. PubMed ID: 26101368
[TBL] [Abstract][Full Text] [Related]
3. Timing and long-term prognosis of recurrent MI after primary angioplasty : Stent thrombosis vs. non-stent-related reinfarction.
Viveiros Monteiro A; Ramos R; Fiarresga A; de Sousa L; Cacela D; Patrício L; Bernardes L; Soares C; Cruz Ferreira R
Herz; 2017 Apr; 42(2):186-193. PubMed ID: 27363417
[TBL] [Abstract][Full Text] [Related]
4. Impact of stress hyperglycemia on in-hospital stent thrombosis and prognosis in nondiabetic patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
Zhang JW; Zhou YJ; Cao SJ; Yang Q; Yang SW; Nie B
Coron Artery Dis; 2013 Aug; 24(5):352-6. PubMed ID: 23835666
[TBL] [Abstract][Full Text] [Related]
5. Role of cathepsin D activation in major adverse cardiovascular events and new-onset heart failure after STEMI.
Yamac AH; Sevgili E; Kucukbuzcu S; Nasifov M; Ismailoglu Z; Kilic E; Ercan C; Jafarov P; Uyarel H; Bacaksiz A
Herz; 2015 Sep; 40(6):912-20. PubMed ID: 25911051
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction.
Baumann S; Huseynov A; Koepp J; Jabbour C; Behnes M; Becher T; Renker M; Lang S; Borggrefe M; Lehmann R; Akin I
Angiology; 2016 Mar; 67(3):272-80. PubMed ID: 26032849
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study.
Kaya MG; Akpek M; Lam YY; Yarlioglues M; Celik T; Gunebakmaz O; Duran M; Ulucan S; Keser A; Oguzhan A; Gibson MC
Int J Cardiol; 2013 Sep; 168(2):1154-9. PubMed ID: 23219132
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
[TBL] [Abstract][Full Text] [Related]
9. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
[TBL] [Abstract][Full Text] [Related]
11. Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy).
Kirtane AJ; Sandhu P; Mehran R; McEntegart M; Cristea E; Brener SJ; Xu K; Fahy M; Généreux P; Wessler JD; Stone GW
Am J Cardiol; 2014 Jan; 113(1):36-43. PubMed ID: 24169019
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
[TBL] [Abstract][Full Text] [Related]
13. Differential 1-year clinical outcomes for ST-segment elevation myocardial infarction related to stent thrombosis or saphenous vein graft thrombosis.
Arzamendi D; Ly HQ; Tanguay JF; Armero S; Jilaihawi H; Gallo R; Ibrahim R; L'Allier P; Blondeau L; Gosselin G; Gregoire J; Doucet S
Catheter Cardiovasc Interv; 2013 Aug; 82(2):193-200. PubMed ID: 21805615
[TBL] [Abstract][Full Text] [Related]
14. CRUSADE bleeding risk score validation for ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Ariza-Solé A; Sánchez-Elvira G; Sánchez-Salado JC; Lorente-Tordera V; Salazar-Mendiguchía J; Sánchez-Prieto R; Romaguera-Torres R; Ferreiro-Gutiérrez JL; Gómez-Hospital JA; Cequier-Fillat A
Thromb Res; 2013; 132(6):652-8. PubMed ID: 24112751
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction.
Wijnbergen I; Tijssen J; van 't Veer M; Michels R; Pijls NH
Catheter Cardiovasc Interv; 2013 Sep; 82(3):379-84. PubMed ID: 23553888
[TBL] [Abstract][Full Text] [Related]
16. Fever after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction is associated with adverse outcomes.
Cho HO; Nam CW; Lee HM; Shin HW; Cho YK; Yoon HJ; Park HS; Kim H; Chung IS; Hur SH; Kim YN; Kim KB
Int J Cardiol; 2014 Jan; 170(3):376-80. PubMed ID: 24290071
[TBL] [Abstract][Full Text] [Related]
17. Cardiac troponin elevation pattern in patients undergoing a primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: characterization and relationship with cardiovascular events during hospitalization.
Buber J; Laish-Farkash A; Koren-Morag N; Fefer P; Segev A; Hod H; Matetzky S
Coron Artery Dis; 2015 Sep; 26(6):503-9. PubMed ID: 26061436
[TBL] [Abstract][Full Text] [Related]
18. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
[TBL] [Abstract][Full Text] [Related]
19. Contemporary analysis of incidence and outcomes of stent thrombosis presenting as ST elevation myocardial infarction in a primary percutaneous coronary intervention cohort.
Jones DA; Gallagher S; Rathod KS; Akhtar M; Knight CJ; Rothman MT; Kapur A; Mathur A; Jain AK; Timmis AD; Smith EJ; Wragg A
Am J Cardiol; 2013 Nov; 112(9):1347-54. PubMed ID: 24012030
[TBL] [Abstract][Full Text] [Related]
20. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Xie XJ; Fang Q; Zhang SY; Fang ZJ; Jiang XF; Xie HZ; Liu ZY; Shen ZJ
Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):265-8. PubMed ID: 21418873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
